Mathematical Pathological Approach as a Novel Tool for Prognosis in Breast Cancer

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249

Article  PubMed  Google Scholar 

International Agency for Research on Cancer. India Source: Globocan 2020. [cited 12th October 2022]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf .

Chopra B, Kaur V, Singh K, Verma M, Singh S, Singh A (2014) Age shift: breast cancer is occurring in younger age groups—is it true? Clin Cancer Investig J 3:526–529

Article  Google Scholar 

Edgerton ME, Chuang YL, Macklin P, Yang W, Bearer EL, Cristini V (2011) A novel, patient-specific mathematical pathology approach for assessment of surgical volume: application to ductal carcinoma in situ of the breast. Anal Cell Pathol (Amst) 34:247–263

Article  PubMed  Google Scholar 

Chan DS, Norat T (2015) Obesity and breast cancer: not only a risk factor of the disease. Curr Treat Options Oncol 16:22

Article  PubMed  Google Scholar 

Malvia S, Bagadi SA, Dubey US, Saxena S (2017) Epidemiology of breast cancer in Indian women. Asia Pac J Clin Oncol 13:289–295

Article  PubMed  Google Scholar 

Cristini V, Lowengrub J, Nie Q (2003) Nonlinear simulation of tumor growth. J Math Biol 46:191–224

Article  PubMed  Google Scholar 

Macklin P, Edgerton ME. Agent-based cell modeling: application to breast cancer. In Multiscale modeling of cancer: an integrated experimental and mathematical modeling approach. Vol. 9780521884426. Cambridge University Press. 2010. p. 206–34.

Macklin P, Edgerton ME, Thompson AM, Cristini V (2012) Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression. J Theor Biol 301:122–140

Article  PubMed  PubMed Central  Google Scholar 

Owen MR, Byrne HM, Lewis CE (2004) Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites. J Theor Biol 226:377–391

Article  PubMed  Google Scholar 

Cronin M, Sangli C, Liu ML, Pho M, Dutta D, Nguyen A et al (2007) Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer. Clin Chem 53:1084–1091

Article  PubMed  Google Scholar 

Kaklamani V (2006) A genetic signature can predict prognosis and response to therapy in breast cancer: oncotype DX. Expert Rev Mol Diagn 6:803–809

Article  PubMed  Google Scholar 

Glas AM, Floore A, Delahaye LJ, Witteveen AT, Pover RC, Bakx N et al (2006) Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 7:278

Article  PubMed  PubMed Central  Google Scholar 

Mook S, Schmidt MK, Viale G, Pruneri G, Eekhout I, Floore A et al (2009) The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study. Breast Cancer Res Treat 116:295–302

Article  PubMed  Google Scholar 

Bedard PL, Mook S, Piccart-Gebhart MJ, Rutgers ET, Van’t Veer LJ, Cardoso F (2009) MammaPrint 70-gene profile quantifies the likelihood of recurrence for early breast cancer. Expert Opin Med Diagn 3:193–205

Article  PubMed  Google Scholar 

Buyse M, Loi S, van’t Veer L, Viale G, Delorenzi M, Glas AM, et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst. 2006;98:1183–92.

Wallden B, Storhoff J, Nielsen T, Dowidar N, Schaper C, Ferree S et al (2015) Development and verification of the PAM50-based Prosigna breast cancer gene signature assay. BMC Med Genomics 8:54

Article  PubMed  PubMed Central  Google Scholar 

Jankowitz RC, Cooper K, Erlander MG, Ma XJ, Kesty NC, Li H et al (2011) Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer. Breast Cancer Res 13:R98

Article  PubMed  PubMed Central  Google Scholar 

Ma XJ, Salunga R, Dahiya S, Wang W, Carney E, Durbecq V et al (2008) A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer. Clin Cancer Res 14:2601–2608

Article  PubMed  Google Scholar 

Rummel S, Hueman MT, Costantino N, Shriver CD, Ellsworth RE (2015) Tumour location within the breast: does tumour site have prognostic ability? Ecancermedicalscience 9:552

Article  PubMed  PubMed Central  Google Scholar 

Surakasula A, Nagarjunapu GC, Raghavaiah KV (2014) A comparative study of pre- and post-menopausal breast cancer: risk factors, presentation, characteristics and management. J Res Pharm Pract 3:12–18

Article  PubMed  PubMed Central  Google Scholar 

Zheng K, Tan JX, Li F, Li HY, Zeng XH, Ma BL et al (2018) Clinicopathologic factors related to the histological tumor grade of breast cancer in Western China: an epidemiological multicenter study of 8619 female patients. Transl Oncol 11:1023–1033

Article  PubMed  PubMed Central  Google Scholar 

Shankar S, Boyanagari M, Boyanagari VK, Shankar M, Ayyanar RS (2018) Profile of breast cancer patients receiving government sponsored free treatment and the associated economic costs. Clinical Epidemiology and Global Health 6:203–207

Article  Google Scholar 

Mathew A, George PS, Ramadas K, Mathew BS, Kumar A, Roshni S et al (2019) Sociodemographic factors and stage of cancer at diagnosis: a population-based study in South India. J Glob Oncol 5:1–10

PubMed  Google Scholar 

Agarwal G, Ramakant P (2008) Breast cancer care in India: the current scenario and the challenges for the future. Breast Care (Basel) 3:21–27

Article  PubMed  Google Scholar 

Shet T, Agrawal A, Nadkarni M, Palkar M, Havaldar R, Parmar V et al (2009) Hormone receptors over the last 8 years in a cancer referral center in India: what was and what is? Indian J Pathol Microbiol 52:171–174

Article  PubMed  Google Scholar 

Kumar N, Patni P, Agarwal A, Khan MA, Parashar N (2015) Prevalence of molecular subtypes of invasive breast cancer: a retrospective study. Med J Armed Forces India 71:254–258

Article  PubMed  PubMed Central  Google Scholar 

Khanna M, Kaur K, Manjari M, Khanna A (2016) Ki67 expression in triple negative breast cancer: correlation of Ki67 expression with other prognostic factors in breast cancer in Indian patients. Trop J Pathol Microbiol 2:76–81

Article  Google Scholar 

Kamalabadi-Farahani M, Najafabadi MRH, Jabbarpour Z (2019) Apoptotic resistance of metastatic tumor cells in triple negative breast cancer: roles of death receptor-5. Asian Pac J Cancer Prev 20:1743–8

Article  PubMed  PubMed Central  Google Scholar 

Minchinton AI, Tannock IF (2006) Drug penetration in solid tumours. Nat Rev Cancer 6:583–592

Article  PubMed  Google Scholar 

Grantab R, Sivananthan S, Tannock IF (2006) The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Cancer Res 66:1033–1039

Article  PubMed  Google Scholar 

Kuh HJ, Jang SH, Wientjes MG, Weaver JR, Au JL (1999) Determinants of paclitaxel penetration and accumulation in human solid tumor. J Pharmacol Exp Ther 290:871–880

PubMed  Google Scholar 

Kyle AH, Huxham LA, Chiam AS, Sim DH, Minchinton AI (2004) Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture. Cancer Res 64:6304–6309

Article  PubMed  Google Scholar 

Phillips RM, Loadman PM, Cronin BP (1998) Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours. Br J Cancer 77:2112–2119

Article  PubMed  PubMed Central  Google Scholar 

Tannock IF, Lee CM, Tunggal JK, Cowan DS, Egorin MJ (2002) Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Clin Cancer Res 8:878–884

PubMed  Google Scholar 

Trop I, LeBlanc SM, David J, Lalonde L, Tran-Thanh D, Labelle M et al (2014) Molecular classification of infiltrating breast cancer: toward personalized therapy. Radiographics 34:1178–1195

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif